{"schema_version":"secwatch.filing_event.v1","accession":"0001434647-25-000018","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.403614+00:00","generated_at":"2026-05-16T12:54:20.103905+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Zevra appoints Timothy Sangiovanni as interim CFO effective Jan 1, 2026","bullets":["Timothy Sangiovanni named interim principal financial officer, effective January 1, 2026.","Sangiovanni currently serves as SVP Finance and Corporate Controller; joined company in 2015.","No change in compensation arrangements in connection with the appointment.","No information provided on predecessor's departure or timing of permanent CFO search."],"urls":{"canonical":"https://secwatch.observer/filing/0001434647-25-000018","json":"https://secwatch.observer/filing/0001434647-25-000018.json","markdown":"https://secwatch.observer/filing/0001434647-25-000018.md","text":"https://secwatch.observer/filing/0001434647-25-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/0001434647-25-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/zvra-20251211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:54:20.103905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}